nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Carboplatin—testicular cancer	0.115	0.155	CbGbCtD
Levetiracetam—ABCC2—Vinblastine—testicular cancer	0.107	0.144	CbGbCtD
Levetiracetam—ABCC2—Cisplatin—testicular cancer	0.0984	0.132	CbGbCtD
Levetiracetam—ABCC2—Etoposide—testicular cancer	0.0967	0.13	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—testicular cancer	0.066	0.0886	CbGbCtD
Levetiracetam—ABCC2—Methotrexate—testicular cancer	0.0639	0.0858	CbGbCtD
Levetiracetam—ABCB1—Dactinomycin—testicular cancer	0.0559	0.0751	CbGbCtD
Levetiracetam—ABCB1—Vinblastine—testicular cancer	0.035	0.047	CbGbCtD
Levetiracetam—ABCB1—Cisplatin—testicular cancer	0.0321	0.0431	CbGbCtD
Levetiracetam—ABCB1—Etoposide—testicular cancer	0.0315	0.0424	CbGbCtD
Levetiracetam—ABCB1—Doxorubicin—testicular cancer	0.0215	0.0289	CbGbCtD
Levetiracetam—ABCB1—Methotrexate—testicular cancer	0.0208	0.028	CbGbCtD
Levetiracetam—SV2A—seminal vesicle—testicular cancer	0.0132	0.274	CbGeAlD
Levetiracetam—SV2A—female gonad—testicular cancer	0.00778	0.161	CbGeAlD
Levetiracetam—SV2A—testis—testicular cancer	0.0069	0.143	CbGeAlD
Levetiracetam—SV2A—lymph node—testicular cancer	0.005	0.103	CbGeAlD
Levetiracetam—CACNA1B—testis—testicular cancer	0.00477	0.0986	CbGeAlD
Levetiracetam—CACNA1B—lymph node—testicular cancer	0.00346	0.0715	CbGeAlD
Levetiracetam—ABCC2—testis—testicular cancer	0.00154	0.0319	CbGeAlD
Levetiracetam—ABCB1—embryo—testicular cancer	0.00114	0.0235	CbGeAlD
Levetiracetam—ABCC2—lymph node—testicular cancer	0.00112	0.0231	CbGeAlD
Levetiracetam—ABCB1—seminal vesicle—testicular cancer	0.00107	0.022	CbGeAlD
Levetiracetam—ABCB1—gonad—testicular cancer	0.000771	0.0159	CbGeAlD
Levetiracetam—ABCB1—female gonad—testicular cancer	0.000626	0.0129	CbGeAlD
Levetiracetam—ABCB1—testis—testicular cancer	0.000555	0.0115	CbGeAlD
Levetiracetam—ABCB1—lymph node—testicular cancer	0.000403	0.00832	CbGeAlD
Levetiracetam—Infestation NOS—Methotrexate—testicular cancer	0.000248	0.00119	CcSEcCtD
Levetiracetam—Depression—Methotrexate—testicular cancer	0.000247	0.00119	CcSEcCtD
Levetiracetam—Pancytopenia—Epirubicin—testicular cancer	0.000247	0.00119	CcSEcCtD
Levetiracetam—Rash—Bleomycin—testicular cancer	0.000246	0.00119	CcSEcCtD
Levetiracetam—Pain—Cisplatin—testicular cancer	0.000246	0.00119	CcSEcCtD
Levetiracetam—Dermatitis—Bleomycin—testicular cancer	0.000246	0.00119	CcSEcCtD
Levetiracetam—Hypersensitivity—Ifosfamide—testicular cancer	0.000246	0.00119	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000245	0.00118	CcSEcCtD
Levetiracetam—Muscular weakness—Doxorubicin—testicular cancer	0.000245	0.00118	CcSEcCtD
Levetiracetam—Neutropenia—Epirubicin—testicular cancer	0.000243	0.00117	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000241	0.00116	CcSEcCtD
Levetiracetam—Stomatitis—Methotrexate—testicular cancer	0.000241	0.00116	CcSEcCtD
Levetiracetam—Conjunctivitis—Methotrexate—testicular cancer	0.000241	0.00116	CcSEcCtD
Levetiracetam—Asthma—Doxorubicin—testicular cancer	0.00024	0.00116	CcSEcCtD
Levetiracetam—Influenza—Doxorubicin—testicular cancer	0.00024	0.00116	CcSEcCtD
Levetiracetam—Asthenia—Ifosfamide—testicular cancer	0.000239	0.00115	CcSEcCtD
Levetiracetam—Eosinophilia—Doxorubicin—testicular cancer	0.000238	0.00115	CcSEcCtD
Levetiracetam—Feeling abnormal—Cisplatin—testicular cancer	0.000237	0.00114	CcSEcCtD
Levetiracetam—Paraesthesia—Etoposide—testicular cancer	0.000237	0.00114	CcSEcCtD
Levetiracetam—Weight increased—Epirubicin—testicular cancer	0.000236	0.00114	CcSEcCtD
Levetiracetam—Pruritus—Ifosfamide—testicular cancer	0.000236	0.00114	CcSEcCtD
Levetiracetam—Pancreatitis—Doxorubicin—testicular cancer	0.000236	0.00114	CcSEcCtD
Levetiracetam—Weight decreased—Epirubicin—testicular cancer	0.000235	0.00113	CcSEcCtD
Levetiracetam—Somnolence—Etoposide—testicular cancer	0.000234	0.00113	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Methotrexate—testicular cancer	0.000234	0.00113	CcSEcCtD
Levetiracetam—Epistaxis—Methotrexate—testicular cancer	0.000233	0.00113	CcSEcCtD
Levetiracetam—Nausea—Bleomycin—testicular cancer	0.000232	0.00112	CcSEcCtD
Levetiracetam—Infestation—Epirubicin—testicular cancer	0.000232	0.00112	CcSEcCtD
Levetiracetam—Infestation NOS—Epirubicin—testicular cancer	0.000232	0.00112	CcSEcCtD
Levetiracetam—Drowsiness—Epirubicin—testicular cancer	0.000232	0.00112	CcSEcCtD
Levetiracetam—Vomiting—Dactinomycin—testicular cancer	0.000232	0.00112	CcSEcCtD
Levetiracetam—Bronchitis—Doxorubicin—testicular cancer	0.000231	0.00111	CcSEcCtD
Levetiracetam—Agranulocytosis—Methotrexate—testicular cancer	0.000231	0.00111	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00023	0.00111	CcSEcCtD
Levetiracetam—Rash—Dactinomycin—testicular cancer	0.00023	0.00111	CcSEcCtD
Levetiracetam—Decreased appetite—Etoposide—testicular cancer	0.000229	0.0011	CcSEcCtD
Levetiracetam—Diarrhoea—Ifosfamide—testicular cancer	0.000228	0.0011	CcSEcCtD
Levetiracetam—Pancytopenia—Doxorubicin—testicular cancer	0.000228	0.0011	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Etoposide—testicular cancer	0.000228	0.0011	CcSEcCtD
Levetiracetam—Body temperature increased—Cisplatin—testicular cancer	0.000227	0.0011	CcSEcCtD
Levetiracetam—Fatigue—Etoposide—testicular cancer	0.000227	0.0011	CcSEcCtD
Levetiracetam—Stomatitis—Epirubicin—testicular cancer	0.000226	0.00109	CcSEcCtD
Levetiracetam—Constipation—Etoposide—testicular cancer	0.000225	0.00109	CcSEcCtD
Levetiracetam—Pain—Etoposide—testicular cancer	0.000225	0.00109	CcSEcCtD
Levetiracetam—Urinary tract infection—Epirubicin—testicular cancer	0.000225	0.00109	CcSEcCtD
Levetiracetam—Conjunctivitis—Epirubicin—testicular cancer	0.000225	0.00109	CcSEcCtD
Levetiracetam—Neutropenia—Doxorubicin—testicular cancer	0.000225	0.00108	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000223	0.00108	CcSEcCtD
Levetiracetam—Hepatitis—Methotrexate—testicular cancer	0.000222	0.00107	CcSEcCtD
Levetiracetam—Dizziness—Ifosfamide—testicular cancer	0.000221	0.00106	CcSEcCtD
Levetiracetam—Pharyngitis—Methotrexate—testicular cancer	0.000221	0.00106	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Epirubicin—testicular cancer	0.000219	0.00106	CcSEcCtD
Levetiracetam—Weight increased—Doxorubicin—testicular cancer	0.000219	0.00105	CcSEcCtD
Levetiracetam—Epistaxis—Epirubicin—testicular cancer	0.000218	0.00105	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—testicular cancer	0.000217	0.00105	CcSEcCtD
Levetiracetam—Sinusitis—Epirubicin—testicular cancer	0.000217	0.00105	CcSEcCtD
Levetiracetam—Feeling abnormal—Etoposide—testicular cancer	0.000217	0.00105	CcSEcCtD
Levetiracetam—Nausea—Dactinomycin—testicular cancer	0.000216	0.00104	CcSEcCtD
Levetiracetam—Agranulocytosis—Epirubicin—testicular cancer	0.000216	0.00104	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Etoposide—testicular cancer	0.000215	0.00104	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—testicular cancer	0.000214	0.00103	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—testicular cancer	0.000214	0.00103	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—testicular cancer	0.000214	0.00103	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000212	0.00102	CcSEcCtD
Levetiracetam—Vomiting—Ifosfamide—testicular cancer	0.000212	0.00102	CcSEcCtD
Levetiracetam—Hypersensitivity—Cisplatin—testicular cancer	0.000212	0.00102	CcSEcCtD
Levetiracetam—Rash—Ifosfamide—testicular cancer	0.00021	0.00101	CcSEcCtD
Levetiracetam—Dermatitis—Ifosfamide—testicular cancer	0.00021	0.00101	CcSEcCtD
Levetiracetam—Erythema multiforme—Methotrexate—testicular cancer	0.00021	0.00101	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—testicular cancer	0.000209	0.00101	CcSEcCtD
Levetiracetam—Rhinitis—Epirubicin—testicular cancer	0.000208	0.00101	CcSEcCtD
Levetiracetam—Abdominal pain—Etoposide—testicular cancer	0.000208	0.001	CcSEcCtD
Levetiracetam—Body temperature increased—Etoposide—testicular cancer	0.000208	0.001	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—testicular cancer	0.000208	0.001	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—testicular cancer	0.000208	0.001	CcSEcCtD
Levetiracetam—Hepatitis—Epirubicin—testicular cancer	0.000208	0.001	CcSEcCtD
Levetiracetam—Eye disorder—Methotrexate—testicular cancer	0.000208	0.001	CcSEcCtD
Levetiracetam—Asthenia—Cisplatin—testicular cancer	0.000206	0.000995	CcSEcCtD
Levetiracetam—Pharyngitis—Epirubicin—testicular cancer	0.000206	0.000995	CcSEcCtD
Levetiracetam—Connective tissue disorder—Epirubicin—testicular cancer	0.000204	0.000985	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000203	0.000977	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—testicular cancer	0.000202	0.000975	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—testicular cancer	0.000201	0.00097	CcSEcCtD
Levetiracetam—Immune system disorder—Methotrexate—testicular cancer	0.000201	0.000968	CcSEcCtD
Levetiracetam—Mediastinal disorder—Methotrexate—testicular cancer	0.0002	0.000966	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—testicular cancer	0.0002	0.000964	CcSEcCtD
Levetiracetam—Nausea—Ifosfamide—testicular cancer	0.000198	0.000956	CcSEcCtD
Levetiracetam—Diarrhoea—Cisplatin—testicular cancer	0.000197	0.000949	CcSEcCtD
Levetiracetam—Erythema multiforme—Epirubicin—testicular cancer	0.000197	0.000948	CcSEcCtD
Levetiracetam—Alopecia—Methotrexate—testicular cancer	0.000196	0.000947	CcSEcCtD
Levetiracetam—Mental disorder—Methotrexate—testicular cancer	0.000195	0.000939	CcSEcCtD
Levetiracetam—Eye disorder—Epirubicin—testicular cancer	0.000194	0.000937	CcSEcCtD
Levetiracetam—Hypersensitivity—Etoposide—testicular cancer	0.000194	0.000936	CcSEcCtD
Levetiracetam—Malnutrition—Methotrexate—testicular cancer	0.000193	0.000933	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—testicular cancer	0.000193	0.00093	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—testicular cancer	0.000192	0.000928	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—testicular cancer	0.000191	0.000921	CcSEcCtD
Levetiracetam—Asthenia—Etoposide—testicular cancer	0.000189	0.000912	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—testicular cancer	0.000189	0.000912	CcSEcCtD
Levetiracetam—Immune system disorder—Epirubicin—testicular cancer	0.000188	0.000906	CcSEcCtD
Levetiracetam—Mediastinal disorder—Epirubicin—testicular cancer	0.000187	0.000904	CcSEcCtD
Levetiracetam—Back pain—Methotrexate—testicular cancer	0.000187	0.000902	CcSEcCtD
Levetiracetam—Pruritus—Etoposide—testicular cancer	0.000186	0.000899	CcSEcCtD
Levetiracetam—Alopecia—Epirubicin—testicular cancer	0.000184	0.000886	CcSEcCtD
Levetiracetam—Vomiting—Cisplatin—testicular cancer	0.000183	0.000882	CcSEcCtD
Levetiracetam—Vision blurred—Methotrexate—testicular cancer	0.000182	0.000879	CcSEcCtD
Levetiracetam—Mental disorder—Epirubicin—testicular cancer	0.000182	0.000878	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—testicular cancer	0.000182	0.000877	CcSEcCtD
Levetiracetam—Rash—Cisplatin—testicular cancer	0.000181	0.000875	CcSEcCtD
Levetiracetam—Dermatitis—Cisplatin—testicular cancer	0.000181	0.000874	CcSEcCtD
Levetiracetam—Malnutrition—Epirubicin—testicular cancer	0.000181	0.000873	CcSEcCtD
Levetiracetam—Diarrhoea—Etoposide—testicular cancer	0.00018	0.000869	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—testicular cancer	0.00018	0.000867	CcSEcCtD
Levetiracetam—Tension—Epirubicin—testicular cancer	0.000178	0.000857	CcSEcCtD
Levetiracetam—Nervousness—Epirubicin—testicular cancer	0.000176	0.000848	CcSEcCtD
Levetiracetam—Back pain—Epirubicin—testicular cancer	0.000175	0.000844	CcSEcCtD
Levetiracetam—Dizziness—Etoposide—testicular cancer	0.000174	0.00084	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—testicular cancer	0.000174	0.000838	CcSEcCtD
Levetiracetam—Vertigo—Methotrexate—testicular cancer	0.000174	0.000838	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—testicular cancer	0.000173	0.000836	CcSEcCtD
Levetiracetam—Leukopenia—Methotrexate—testicular cancer	0.000173	0.000835	CcSEcCtD
Levetiracetam—Nausea—Cisplatin—testicular cancer	0.000171	0.000824	CcSEcCtD
Levetiracetam—Vision blurred—Epirubicin—testicular cancer	0.000171	0.000823	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—testicular cancer	0.00017	0.00082	CcSEcCtD
Levetiracetam—Cough—Methotrexate—testicular cancer	0.000169	0.000814	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—testicular cancer	0.000169	0.000813	CcSEcCtD
Levetiracetam—Convulsion—Methotrexate—testicular cancer	0.000168	0.000808	CcSEcCtD
Levetiracetam—Vomiting—Etoposide—testicular cancer	0.000168	0.000808	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—testicular cancer	0.000167	0.000808	CcSEcCtD
Levetiracetam—Agitation—Epirubicin—testicular cancer	0.000166	0.000802	CcSEcCtD
Levetiracetam—Rash—Etoposide—testicular cancer	0.000166	0.000801	CcSEcCtD
Levetiracetam—Dermatitis—Etoposide—testicular cancer	0.000166	0.000801	CcSEcCtD
Levetiracetam—Headache—Etoposide—testicular cancer	0.000165	0.000796	CcSEcCtD
Levetiracetam—Arthralgia—Methotrexate—testicular cancer	0.000165	0.000794	CcSEcCtD
Levetiracetam—Chest pain—Methotrexate—testicular cancer	0.000165	0.000794	CcSEcCtD
Levetiracetam—Myalgia—Methotrexate—testicular cancer	0.000165	0.000794	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—testicular cancer	0.000164	0.000793	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000164	0.000789	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—testicular cancer	0.000163	0.000784	CcSEcCtD
Levetiracetam—Vertigo—Epirubicin—testicular cancer	0.000163	0.000784	CcSEcCtD
Levetiracetam—Leukopenia—Epirubicin—testicular cancer	0.000162	0.000781	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—testicular cancer	0.000162	0.000781	CcSEcCtD
Levetiracetam—Confusional state—Methotrexate—testicular cancer	0.000159	0.000768	CcSEcCtD
Levetiracetam—Cough—Epirubicin—testicular cancer	0.000158	0.000762	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—testicular cancer	0.000158	0.000761	CcSEcCtD
Levetiracetam—Convulsion—Epirubicin—testicular cancer	0.000157	0.000756	CcSEcCtD
Levetiracetam—Infection—Methotrexate—testicular cancer	0.000157	0.000756	CcSEcCtD
Levetiracetam—Nausea—Etoposide—testicular cancer	0.000157	0.000755	CcSEcCtD
Levetiracetam—Nervous system disorder—Methotrexate—testicular cancer	0.000155	0.000746	CcSEcCtD
Levetiracetam—Thrombocytopenia—Methotrexate—testicular cancer	0.000155	0.000745	CcSEcCtD
Levetiracetam—Myalgia—Epirubicin—testicular cancer	0.000154	0.000743	CcSEcCtD
Levetiracetam—Chest pain—Epirubicin—testicular cancer	0.000154	0.000743	CcSEcCtD
Levetiracetam—Arthralgia—Epirubicin—testicular cancer	0.000154	0.000743	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—testicular cancer	0.000154	0.000742	CcSEcCtD
Levetiracetam—Anxiety—Epirubicin—testicular cancer	0.000154	0.000741	CcSEcCtD
Levetiracetam—Skin disorder—Methotrexate—testicular cancer	0.000153	0.000739	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000153	0.000738	CcSEcCtD
Levetiracetam—Vertigo—Doxorubicin—testicular cancer	0.00015	0.000726	CcSEcCtD
Levetiracetam—Anorexia—Methotrexate—testicular cancer	0.00015	0.000726	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—testicular cancer	0.00015	0.000723	CcSEcCtD
Levetiracetam—Confusional state—Epirubicin—testicular cancer	0.000149	0.000718	CcSEcCtD
Levetiracetam—Infection—Epirubicin—testicular cancer	0.000147	0.000708	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—testicular cancer	0.000146	0.000705	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—testicular cancer	0.000145	0.0007	CcSEcCtD
Levetiracetam—Nervous system disorder—Epirubicin—testicular cancer	0.000145	0.000699	CcSEcCtD
Levetiracetam—Thrombocytopenia—Epirubicin—testicular cancer	0.000145	0.000697	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000144	0.000693	CcSEcCtD
Levetiracetam—Skin disorder—Epirubicin—testicular cancer	0.000143	0.000692	CcSEcCtD
Levetiracetam—Insomnia—Methotrexate—testicular cancer	0.000143	0.000688	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—testicular cancer	0.000143	0.000688	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—testicular cancer	0.000143	0.000688	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—testicular cancer	0.000143	0.000688	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—testicular cancer	0.000142	0.000685	CcSEcCtD
Levetiracetam—Paraesthesia—Methotrexate—testicular cancer	0.000142	0.000684	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000142	0.000683	CcSEcCtD
Levetiracetam—Anorexia—Epirubicin—testicular cancer	0.000141	0.000679	CcSEcCtD
Levetiracetam—Somnolence—Methotrexate—testicular cancer	0.00014	0.000677	CcSEcCtD
Levetiracetam—Dyspepsia—Methotrexate—testicular cancer	0.000139	0.00067	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—testicular cancer	0.000138	0.000665	CcSEcCtD
Levetiracetam—Decreased appetite—Methotrexate—testicular cancer	0.000137	0.000662	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000136	0.000657	CcSEcCtD
Levetiracetam—Fatigue—Methotrexate—testicular cancer	0.000136	0.000656	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—testicular cancer	0.000136	0.000655	CcSEcCtD
Levetiracetam—Pain—Methotrexate—testicular cancer	0.000135	0.000651	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000135	0.000649	CcSEcCtD
Levetiracetam—Nervous system disorder—Doxorubicin—testicular cancer	0.000134	0.000646	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—testicular cancer	0.000134	0.000645	CcSEcCtD
Levetiracetam—Insomnia—Epirubicin—testicular cancer	0.000134	0.000644	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—testicular cancer	0.000133	0.00064	CcSEcCtD
Levetiracetam—Paraesthesia—Epirubicin—testicular cancer	0.000133	0.00064	CcSEcCtD
Levetiracetam—Somnolence—Epirubicin—testicular cancer	0.000131	0.000633	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—testicular cancer	0.00013	0.000628	CcSEcCtD
Levetiracetam—Feeling abnormal—Methotrexate—testicular cancer	0.00013	0.000627	CcSEcCtD
Levetiracetam—Dyspepsia—Epirubicin—testicular cancer	0.00013	0.000627	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Methotrexate—testicular cancer	0.000129	0.000622	CcSEcCtD
Levetiracetam—Decreased appetite—Epirubicin—testicular cancer	0.000128	0.000619	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000128	0.000615	CcSEcCtD
Levetiracetam—Fatigue—Epirubicin—testicular cancer	0.000127	0.000614	CcSEcCtD
Levetiracetam—Pain—Epirubicin—testicular cancer	0.000126	0.000609	CcSEcCtD
Levetiracetam—Constipation—Epirubicin—testicular cancer	0.000126	0.000609	CcSEcCtD
Levetiracetam—Abdominal pain—Methotrexate—testicular cancer	0.000125	0.000602	CcSEcCtD
Levetiracetam—Body temperature increased—Methotrexate—testicular cancer	0.000125	0.000602	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000125	0.000601	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—testicular cancer	0.000124	0.000596	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—testicular cancer	0.000123	0.000592	CcSEcCtD
Levetiracetam—Feeling abnormal—Epirubicin—testicular cancer	0.000122	0.000587	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—testicular cancer	0.000122	0.000586	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Epirubicin—testicular cancer	0.000121	0.000582	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—testicular cancer	0.00012	0.00058	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—testicular cancer	0.000119	0.000573	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000118	0.000569	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—testicular cancer	0.000118	0.000568	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—testicular cancer	0.000117	0.000564	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—testicular cancer	0.000117	0.000564	CcSEcCtD
Levetiracetam—Body temperature increased—Epirubicin—testicular cancer	0.000117	0.000563	CcSEcCtD
Levetiracetam—Abdominal pain—Epirubicin—testicular cancer	0.000117	0.000563	CcSEcCtD
Levetiracetam—Hypersensitivity—Methotrexate—testicular cancer	0.000116	0.000561	CcSEcCtD
Levetiracetam—Asthenia—Methotrexate—testicular cancer	0.000113	0.000546	CcSEcCtD
Levetiracetam—Feeling abnormal—Doxorubicin—testicular cancer	0.000113	0.000543	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000112	0.000539	CcSEcCtD
Levetiracetam—Pruritus—Methotrexate—testicular cancer	0.000112	0.000539	CcSEcCtD
Levetiracetam—Hypersensitivity—Epirubicin—testicular cancer	0.000109	0.000525	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—testicular cancer	0.000108	0.000521	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—testicular cancer	0.000108	0.000521	CcSEcCtD
Levetiracetam—Diarrhoea—Methotrexate—testicular cancer	0.000108	0.000521	CcSEcCtD
Levetiracetam—Asthenia—Epirubicin—testicular cancer	0.000106	0.000511	CcSEcCtD
Levetiracetam—Pruritus—Epirubicin—testicular cancer	0.000105	0.000504	CcSEcCtD
Levetiracetam—Dizziness—Methotrexate—testicular cancer	0.000104	0.000503	CcSEcCtD
Levetiracetam—Diarrhoea—Epirubicin—testicular cancer	0.000101	0.000487	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—testicular cancer	0.000101	0.000486	CcSEcCtD
Levetiracetam—Vomiting—Methotrexate—testicular cancer	0.0001	0.000484	CcSEcCtD
Levetiracetam—Rash—Methotrexate—testicular cancer	9.95e-05	0.00048	CcSEcCtD
Levetiracetam—Dermatitis—Methotrexate—testicular cancer	9.94e-05	0.000479	CcSEcCtD
Levetiracetam—Headache—Methotrexate—testicular cancer	9.89e-05	0.000477	CcSEcCtD
Levetiracetam—Asthenia—Doxorubicin—testicular cancer	9.81e-05	0.000473	CcSEcCtD
Levetiracetam—Dizziness—Epirubicin—testicular cancer	9.77e-05	0.000471	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—testicular cancer	9.67e-05	0.000466	CcSEcCtD
Levetiracetam—Vomiting—Epirubicin—testicular cancer	9.39e-05	0.000453	CcSEcCtD
Levetiracetam—Nausea—Methotrexate—testicular cancer	9.38e-05	0.000452	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—testicular cancer	9.35e-05	0.000451	CcSEcCtD
Levetiracetam—Rash—Epirubicin—testicular cancer	9.31e-05	0.000449	CcSEcCtD
Levetiracetam—Dermatitis—Epirubicin—testicular cancer	9.31e-05	0.000449	CcSEcCtD
Levetiracetam—Headache—Epirubicin—testicular cancer	9.25e-05	0.000446	CcSEcCtD
Levetiracetam—Dizziness—Doxorubicin—testicular cancer	9.04e-05	0.000436	CcSEcCtD
Levetiracetam—Nausea—Epirubicin—testicular cancer	8.77e-05	0.000423	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—testicular cancer	8.69e-05	0.000419	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—testicular cancer	8.62e-05	0.000416	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—testicular cancer	8.61e-05	0.000415	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—testicular cancer	8.56e-05	0.000413	CcSEcCtD
Levetiracetam—Nausea—Doxorubicin—testicular cancer	8.12e-05	0.000392	CcSEcCtD
